Kode Biotech
Share
Biosurface innovation by Kode Biotech through the development of a multi-functional nano-paint - Kod
Click here to claim your Sponsored Listing.
The Kode Story
Kode Biotech had its origins in 15 years of academic research by its founder Professor Steve Henry who was studying a natural blood group molecule with the ability to label cell surfaces. A company was established on the campus of AUT University where the company still resides today – whilst maintaining ownership of intellectual property.
In 2001 the first generation Kode™ Technology construct was invented.
From the beginning it was realized that Kode™ Technology was unique and had huge potential so the commercial strategy to become a licensor of the technology was adopted. Recently 2nd and 3rd generation Kode™ constructs have been invented and several significant high value licensed and prototype products are now coming into fruition, including a potential cancer therapy which entered into human clinical trials in August 2018.
With a small team, an established global network, a well protected strategic IP portfolio and a focus on commercialization we are now looking to further accelerate the commercial up take of Kode™ Technology to realize the full potential of the company.
Category
Contact the business
Website
Address
3 Lonsdale Street, Ellerslie
Penrose
1051
Opening Hours
| Monday | 8:30am - 5pm |
| Tuesday | 8:30am - 5pm |
| Wednesday | 8:30am - 5pm |
| Thursday | 8:30am - 5pm |
| Friday | 8:30am - 5pm |
